AmMax Bio Announces the Appointment of Biotechnology Executive, John Varian, as Independent Board Member
AmMax Bio, Inc. (“AmMax”), a private clinical-stage biopharmaceutical company developing innovative treatments with its proprietary dual anti-inflammatory/anti-fibrotic therapeutic platform targeting...